Oral rapamycin to inhibit restenosis after stenting of de novo coronary lesions: The Oral Rapamune to Inhibit Restenosis (ORBIT) study

R Waksman, Andrew E. Ajani, A.D. Pichard

ACC Current Journal Review · 2005 · 49 citations · 0 references

Concepts